Innovation Pharmaceuticals Inc (IPIX)

[rule_rationale]

First of all, polymedix did not go under due to Brilacidin's success, they went under due to a different drug they had in development failing. And I absolutely attribute our trial successes to the brilliance of our management and scientific staff in properly defining trial protocols and all of the successful interaction with regulatory officials as validated by our QIDP designation and the recent Orphan drug for ovarian cancer with Kevetrin. It is absolutely the direct result of how our company has been managed and it is why I continue to invest with Cellceutix.